| The use of ionized iodine for cancer prevention and eradication. | |
| | |
MedLine Citation:
|
PMID: 12027514 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Using an ionized iodine compound, it may be possible to transmit a weak effect of the digestive enzymes from the duodenal lumen to the cytoplasmic structures beyond the cell membrane in general organic tissues. Povidone-iodine is easily obtainable at present, and may be the most suitable ionized material for the transmission of the enzymatic effects to body tissues. Consequently, to remove certain cellular byproducts accumulated abnormally in cancerous cytoplasm, and to achieve cancer prevention and eradication, a method of using povidone-iodine, as a conceptual model, should be devised and developed in the future. |
| | |
Authors:
|
Y Hirata; S Hirata |
Related Documents
:
|
22384974 - The healing and spiritual properties of music therapy at a cancer care center. 19381964 - Magnetic resonance spectroscopy of living tissues. 22322254 - Cancer biomarkers: selecting the right drug for the right patient. 19779254 - Concentration of protoporphyrin ix in cancer tissues and blood in patients with colorec... 17508124 - Computed tomographic colonography: clinical value. 11447764 - Immunity to oncogenic human papillomaviruses. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Medical hypotheses Volume: 58 ISSN: 0306-9877 ISO Abbreviation: Med. Hypotheses Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-05-24 Completed Date: 2003-01-30 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7505668 Medline TA: Med Hypotheses Country: Scotland |
Other Details:
|
Languages: eng Pagination: 254-6 Citation Subset: IM |
Copyright Information:
|
Copyright 2002 Elsevier Science Ltd. All rights reserved. |
Affiliation:
|
Hirata Hospital, Kochi, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anticarcinogenic Agents / therapeutic use* Antineoplastic Agents / administration & dosage, pharmacology, therapeutic use* Cell Transformation, Neoplastic / metabolism Cytoplasm / metabolism Duodenum / enzymology* Gastrointestinal Contents / enzymology* Humans Hydrophobicity Intestinal Mucosa / metabolism Lipids / pharmacokinetics Lymphatic System / physiology Lymphocytes / cytology, metabolism Milk Mitosis Neoplasms / drug therapy*, metabolism, pathology, prevention & control* Povidone-Iodine / administration & dosage, pharmacology, therapeutic use* Protons Solubility |
| Chemical | |
Reg. No./Substance:
|
0/Anticarcinogenic Agents; 0/Antineoplastic Agents; 0/Lipids; 0/Protons; 25655-41-8/Povidone-Iodine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Physio-mitotic theory and a new concept of leukemia development.
Next Document: The precise human bioclock, possibly imported.